Hugel

Beta

KRX Filings & Disclosures 2026

Risk Factors

• • USD 10% exchange rate change → ±KRW 8.46B pre-tax impact on income, largest FX exposure among currencies
• • Credit risk exposure totaled KRW 629B at FY2025-end, up from KRW 491B at FY2024-end

Management Discussion & Analysis

• • Revenue KRW 425.1B (+14.0% YoY), Operating Profit KRW 200.9B (+20.8%), Net Income KRW 147.0B (+2.7%) for FY2025
• • Botulinum toxin sales growth driven by domestic market leadership and above-expected shipments in China and U.S.

Business Overview

• • Core revenue from Botox toxin (54.22%), HA filler "The Chaeum" (30.63%), cosmetics "Wellage" (13.25%), medical devices (1.27%) in FY2025
• • FDA approval Feb 29, 2024 for botulinum toxin product "Letybo" (50unit, 100unit) in US, first Korean toxin in all 3 major markets (US, EU, China)

What are the latest Hugel DART filings in 2026?

Hugel (KRX code 145020) has filed an annual report on March 20, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Hugel file its most recent annual report?

Hugel filed its most recent annual report on March 20, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Hugel's KRX stock code?

Hugel's KRX stock code is 145020. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 145020 to look up all Hugel disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Hugel file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Hugel.

Where can I find Hugel financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Hugel annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.